Want to join the conversation?
$EW's Transcatheter Heart Valve Therapy, or THVT, sales for 2Q16 jumped by 48.7% from last year, or 45.1% on underlying basis, driven by continued strong therapy adoption across all geographies, with notable strength in the U.S. In the U.S., THVT sales climbed 71.5% over last year, or 65.7% on an underlying basis.
$NFLX a monster move, going up. Expect making some money on Monday.
$AMD down more than 6% even after posting above consensus third quarter results.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.